Sophia Genetics SA (SOPH): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
SOPH Stock Price Chart Interactive Chart >
SOPH Price/Volume Stats
| Current price | $17.78 | 52-week high | $19.80 |
| Prev. close | $17.92 | 52-week low | $14.88 |
| Day low | $17.08 | Volume | 54,200 |
| Day high | $18.54 | Avg. volume | 145,617 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.13B |
Sophia Genetics SA (SOPH) Company Bio
Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. The company offers SOPHiA DDM for solid tumors. Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland.
Latest SOPH News From Around the Web
Below are the latest news stories about SOPHiA GENETICS SA that investors may wish to consider to help them evaluate SOPH as an investment opportunity.
SOPHiA GENETICS Reports Second Quarter 2021 Financial Results and Issues 2021 GuidanceBOSTON and LAUSANNE, Switzerland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (NASDAQ: SOPH), today reported financial results for the three months ended June 30, 2021. Recent Highlights Revenue was $10.2 million for the second quarter, representing a 72% increase over the corresponding period of 2020Increased total customer base of hospitals, labs, and biopharma institutions to 780 customers during the second quarter, up from 750 in the first quarter of 2021Strengthened balance sheet |
SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare ConferenceBOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference. SOPHiA GENETICS’ management is scheduled to present on Friday, September 10th at 9:30 a.m. Eastern Time/3:30 p.m. Central European Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: ir.sophiagenet |
SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The companys management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook. |
UPDATE SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The companys management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook. |
UPDATE – SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The company’s management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of th |
SOPH Price Returns
| 1-mo | -2.25% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...